REQUEST A DEMO
Total
USD $0.00
Search more companies

Anwita Drugs & Chemicals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Anwita Drugs & Chemicals Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Anwita Drugs & Chemicals Private Limited is an unlisted company, incorporated on 12/02/2014. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24232TG2014PTC092897 and registration number is 092897. The company is a manufacturing company, it is engaged in plastic products, non-metallic mineral products, rubber products, fabricated metal products.

Headquarters
Plot No. 19-B/1 Plot No. 19-B/2 And Plot No. 19-B/3 Survey No. 810 Phase-Ii Ida Patancheru Medak Hyderabad In-Ts In 502319
Sangareddy; Telangana; Postal Code: 502319

Contact Details: Purchase the Anwita Drugs & Chemicals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Anwita Drugs & Chemicals Private Limited report to view the information.
Registered Capital:
Purchase the Anwita Drugs & Chemicals Private Limited report to view the information.
Incorporation Date:
February 12, 2014
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Anwita Drugs & Chemicals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
84.55%
Total operating revenue
81.72%
Operating profit (EBIT)
-24.99%
EBITDA
3.92%
Net Profit (Loss) for the Period
-50.2%
Total assets
3.05%
Total equity
1.33%
Operating Profit Margin (ROS)
-1.28%
Net Profit Margin
-1.11%
Return on Equity (ROE)
-1.36%
Debt to Equity Ratio
-21.94%
Quick Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?